Abstract

Postsurgical thrombotic microangiopathy (TMA) is a complication associated with significant morbidity and mortality. Still, the pathophysiological underlying mechanism of postsurgical TMA, a diagnosis often overlooked in postoperative patients with acute kidney injury and thrombocytopenia, is largely unknown. Here, we report the case of a 56-year-old male that developed anuric acute kidney injury, Coombs-negative hemolysis, and thrombocytopenia after surgical aortic arch replacement. Massive ex vivo complement activation on the endothelium, a rare complement gene variant in C2, at-risk haplotype MCPggaac, and excellent response to therapeutic complement inhibition, points to the pivotal role of complement in the pathophysiology of disease. Moreover, the importance of a multidisciplinary team approach in (postsurgical) thrombocytopenia is emphasized.

Original languageEnglish
Article number2501
Number of pages7
JournalJournal of Clinical Medicine
Volume11
Issue number9
DOIs
Publication statusPublished - 29 Apr 2022

Keywords

  • ACTIVATION
  • ECULIZUMAB
  • HEME
  • HEMOLYTIC-UREMIC SYNDROME
  • aortic surgery
  • complement activation
  • complement inhibition
  • genetic variance
  • hemolytic uremic syndrome
  • multidisciplinary approach
  • thrombocytopenia
  • thrombotic micro-angiopathy

Cite this